Clinical phase III trials of the Bharat Biotech's COVID-19 nasal vaccine completed
July 16, 2026
  • Read Ecopy
  • Circulation
  • Advertise
  • Careers
  • About Us
  • Contact Us
Android AppiPhone AppArattai
Organiser
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
  • Editorial
  • International
  • Opinion
  • RSS @ 100
  • More
    • Op Sindoor
    • Analysis
    • Sports
    • Defence
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
  • Subscribe
    • Subscribe Print Edition
    • Subscribe Ecopy
    • Read Ecopy
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
  • Editorial
  • International
  • Opinion
  • RSS @ 100
  • More
    • Op Sindoor
    • Analysis
    • Sports
    • Defence
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
  • Subscribe
    • Subscribe Print Edition
    • Subscribe Ecopy
    • Read Ecopy
Organiser
  • Home
  • Bharat
  • World
  • Operation Sindoor
  • Editorial
  • Analysis
  • Opinion
  • Culture
  • Defence
  • International Edition
  • RSS @ 100
  • Magazine
  • Read Ecopy
Home Bharat

Clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine completed

Talking about the Vivatech 2022, Krishna said that this is really great achievement for India, building a brand name in France.

WEBDESKWEBDESK
Jun 19, 2022, 12:20 pm IST
in Bharat
Follow on Google News
FacebookTwitterWhatsAppTelegramEmail

Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data to the Drugs Controller General of India (DCGI) next month.

In an exclusive interview with ANI, Dr Ella said, “We just completed a clinical trial, a data analysis is going on. Next month, we will submit the data to the regulatory agency. If everything is okay, then we will get permission to launch and it will be the world’s first clinically proven nasal COVID-19 vaccine”.

Krishna was in Paris as a speaker at Viva Technology 2022 where India was declared country of the year. India’s drug controller had in January this year given permission to Bharat Biotech to conduct standalone phase III trials on its COVID-19 nasal vaccine. On the booster dose of COVID-19, Krishna said that those who had taken the second dose must take the booster dose.

“Booster dose of vaccine gives immunity. I always say the booster dose is a miracle dose for every vaccination. Even in children first, two doses don’t give much immunity, but the third dose gives an amazing response to the child. The same thing for adults also. The third dose is very important for adults. COVID-19 can’t be eradicated 100 per cent. It will be there and we have to live with it and handle it and more intelligently how to control it,” he said.

Talking about the Vivatech 2022, Krishna said that this is really great achievement for India, building a brand name in France. “I am glad to say 65 startups from India, under NITI Aayog they all came, showing that technology to a lot of people, what India can do, how India can innovate for the world. They are vibrant because I was a startup in 1997.”

He said that earlier United States was the centre of startups but for the first time Indians are getting exposure in France. “I am so happy to say the French government is very practical. They are really encouraging India and with truthfully a good heart. Again, they are really pushing how more the government can work together. How about the country’s startups can work together?”, he said.

“How government policies can create an ecosystem that is scalable, even French President Macron was talking about how to scale it up between the two partnerships, how to scale up for globe and the digitalization all that is talking about infrastructure, digitalization all that they are talking and that is a good sign between the two countries and the first time French is coming closer to India,” he added.

 

Topics: IndiaCOVID-19Bharat BiotechCOVID vaccine
ShareTweetSendShareSend
✮ Subscribe Organiser YouTube Channel. ✮
✮ Join Organiser's WhatsApp channel for Nationalist views beyond the news. ✮
Previous News

PM Modi inaugurates Pragati Maidan Integrated Transit Corridor project in Delhi

Next News

Lok Sabha speaker Om Birla completes 3 years in office; Lok Sabha saves Rs 668.86 crore

Related News

“Reuters-You can do better”: US Envoy Sergio Gor slams British news agency over fake narrative on India-US trade deal

External Affairs Minister Dr. S. Jaishankar launched India's campaign for the UNSC chair

India unveils campaign for UNSC seat; EAM Jaishankar outlines SHANTI vision for secure, peaceful & just world order

Commerce and Industry Minister Piyush Goyal

Fact Check: Piyush Goyal rejects Reuters report on India-US trade deal as “false & misleading”; Reaffirms balanced pact

Great Nicobar is emerging as a strategic gateway that strengthens India's maritime reach while increasing pressure on China's Malacca Dilemma

Great Nicobar Project to boost India’s Indo-Pacific leverage, deepen China’s Malacca Dilemma: Report

PM Modi's Gifts to Albanese Blend India's Ancient Craft, Modern Music and Premium Coffee

From Dhokra Sculpture to Colonial Cousins Vinyl: PM Modi’s gifts to Australian PM Albanese showcases cultural heritage

Prime Minister Narendra Modi and New Zealand Prime Minister Christopher Luxon

India-New Zealand Strategic Partnership: A new horizon for New Delhi’s economic diplomacy

Load More

Latest News

ED

ED cracks down terror funding & infiltration network, raids across UP, Delhi, Haryana & West Bengal

A Hyderabad private school has terminated teacher Farhat Sultana after she allegedly asked a Hindu student to recite the Kalma & Surah Fatiha

Hyderabad School Row: Teacher Farhat Sultana terminated for asking a Hindu student to recite the Kalma & Surah Fatiha

Representative Image

Cabinet approves Rs 62,500 crore mobile phone manufacturing scheme to boost domestic production

Pouchalung Panmei passes away

Manipur: RSS condoles demise of Tamenglong Pracharak’s father Pouchalung Panmei

Dignitaries on the stage along with Telangana Governor at the 15th BRICS Trade Union Forum (BTUF) Summit-2026

15th BRICS Trade Union Forum | Hyderabad declaration charts new path for labour rights: Telangana Governor Shiv Pratap

Eight Kalaburagi Central Prison officials were suspended after three convicts escaped

Karnataka Jail Break: 8 Kalaburagi officials suspended as BJP tears into Congress govt over security lapses

India, Norway ink MoU to harness the natural flow of Himalayan rivers

India, Norway ink MoU to harness natural flow of Himalayan rivers to generate clean energy in Arunachal Pradesh

Kalapahar's 1568 assault on the Jagannath Mandir remains one of the most traumatic episodes in Odisha's history

Kalapahar’s Assault on the Jagannath Mandir: Cultural trauma, Hindu resistance & revival of Odisha’s sacred heritage

Chinnaswamy Stampede: BJP slams Karnataka govt for giving clean chit to IPS officers, questions accountability

Prime Minister Modi to visit Punjab, Haryana and Chandigarh

PM Modi to roll out Rs 26,800 crore development push across Haryana, Chandigarh and Punjab on July 17

Load More
  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

  • Home
  • Search Organiser
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Africa
    • North America
    • South America
    • Europe
    • Australia
  • Editorial
  • Operation Sindoor
  • Opinion
  • Analysis
  • Defence
  • Culture
  • Sports
  • Business
  • RSS @ 100
  • Entertainment
  • More ..
    • Sci & Tech
    • Vocal4Local
    • Special Report
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Health
    • Politics
    • Law
    • Economy
    • Obituary
  • Subscribe Magazine
  • Read Ecopy
  • Advertise
  • Circulation
  • Careers
  • About Us
  • Contact Us
  • Policies & Terms
    • Privacy Policy
    • Cookie Policy
    • Refund and Cancellation
    • Terms of Use

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies